A Synopsis: Neurocardiogenic Syncope, An International Symposium, 1996
暂无分享,去创建一个
M. Gammage | R. Sutton | D. Benditt | M. Erickson | T. Markowitz | R. Sutton | DAVID G. BENDITT | MICHAEL D. GAMMAGE | TOBY MARKOWITZ
[1] M. Gammage. Rate‐Drop Response Programming , 1997, Pacing and clinical electrophysiology : PACE.
[2] R. Kenny,et al. Prevalence of Cardioinhibitory Carotid Sinus Hypersensitivity in Patients 50 Years or over Presenting to the Accident and Emergency Department with “Unexplained” or “Recurrent” Falls , 1997, Pacing and clinical electrophysiology : PACE.
[3] M. Brignole,et al. Detecting Incipient Vasovagal Syncope: Intraventricular Acceleration , 1997, Pacing and clinical electrophysiology : PACE.
[4] M. Gammage,et al. Clinical Experience with Thera DR Rate‐Drop Response Pacing Algorithm in Carotid Sinus Syndrome and Vasovagal Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[5] D. Kosinski,et al. Tilt Table Testing: Concepts and Limitations , 1997, Pacing and clinical electrophysiology : PACE.
[6] S. Markowitz,et al. Response of Neurocardiac Syncope to β‐Blocker Therapy: Interaction Between Age and Parasympathetic Tone , 1997, Pacing and clinical electrophysiology : PACE.
[7] R. Kenny,et al. Cardiovascular Syncope Is the Most Common Cause of Drop Attacks in the Elderly , 1997, Pacing and clinical electrophysiology : PACE.
[8] S. Connolly,et al. North American Vasovagal Pacemaker Study: Study Design and Organization , 1997, Pacing and clinical electrophysiology : PACE.
[9] M. Joyner,et al. Vasovagal Syncope and Skeletal Muscle Vasodilatation: The Continuing Conundrum , 1997, Pacing and clinical electrophysiology : PACE.
[10] R. Sutton,et al. The Economics of Treating Vasovagal Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[11] C. Morillo,et al. Neural Monitoring of Vasovagal Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[12] M. Gammage. Tilt Testing: A Useful Screen for Rate‐Drop Response , 1997, Pacing and clinical electrophysiology : PACE.
[13] M. Petersen,et al. Right Ventricular Pressure, dP/dt, and Preejection Interval During Tilt Induced Vasovagal Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[14] R. Kenny,et al. The Impact of a Dedicated “Syncope and Falls” Clinic on Pacing Practice in Northeastern England , 1997, Pacing and clinical electrophysiology : PACE.
[15] M. Brignole,et al. Methods Other Than Tilt Testing for Diagnosing Neurocardiogenic (Neurally Mediated) Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[16] J. Karemaker,et al. Neural Circulatory Control in Vasovagal Syncope , 1997, Pacing and clinical electrophysiology : PACE.
[17] W. Kapoor,et al. Tilt table testing for assessing syncope , 1996 .
[18] J. Blanc,et al. New insights into the pathophysiology of carotid sinus syndrome. , 1996, Circulation.
[19] P. Flanagan,et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. , 1996, Circulation.
[20] D. Kosinski,et al. Pathophysiological Aspects of Neurocardiogenic Syncope: Current Concepts and New Perspectives , 1995, Pacing and clinical electrophysiology : PACE.
[21] B. Grubb,et al. Cardiac Pacing for Prevention of Recurrent Vasovagal Syncope , 1995, Annals of Internal Medicine.
[22] S. Eggener,et al. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. , 1994, The Journal of physiology.
[23] D. Kosinski,et al. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. , 1994, The American journal of medicine.
[24] A. Fitzpatrick,et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. , 1994, British heart journal.
[25] C. Morillo,et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by heap-up tilt , 1993 .
[26] H Calkins,et al. The economic burden of unrecognized vasodepressor syncope. , 1993, The American journal of medicine.
[27] M. Carlson,et al. Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. , 1993, Journal of the autonomic nervous system.
[28] B. Grubb,et al. Adaptive Rate Pacing Controlled by Right Ventricular Preejection Interval for Severe Refractory Orthostatic Hypotension , 1993, Pacing and clinical electrophysiology : PACE.
[29] P. Njemanze,et al. Critical Limits of Pressure‐Flow Relation in the Human Brain , 1992, Stroke.
[30] M. Brignole,et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. , 1992, The American journal of cardiology.
[31] M. Brignole,et al. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. , 1992, The American journal of cardiology.
[32] H. Saito,et al. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? , 1992, Circulation research.
[33] D. Eckberg,et al. The vasovagal response. , 1991, Clinical science.
[34] B. Grubb,et al. Cerebral Vasoconstriction During Head‐Upright Tilt‐Induced Vasovagal Syncope: A Paradoxic and Unexpected Response , 1991, Circulation.
[35] A. Garson,et al. The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity. , 1991, Journal of the American College of Cardiology.
[36] D. McCloskey,et al. Sympathetic‐parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs. , 1990, The Journal of physiology.
[37] J. Johnson,et al. Baroreflex control of the cutaneous active vasodilator system in humans. , 1990, Circulation research.
[38] G. Perna,et al. Increase of plasma beta endorphins in vasodepressor syncope. , 1990, The American journal of cardiology.
[39] S. Lightman,et al. Pathogenic role for argenine vasopressin (AVP) and catecholamines (EP & NEP) in vasovagal syncope , 1990 .
[40] M. N. Levy,et al. Inhibition of Cardiac Vagal Effects by Neurally Released and Exogenous Neuropeptide Y , 1989, Circulation research.
[41] J. Ludbrook,et al. Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated haemorrhage in awake rabbits. , 1989, The Journal of physiology.
[42] E. Potter. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y , 1987, Neuroscience Letters.
[43] J. Bevan,et al. Nonadrenergic neural vasodilator mechanisms. , 1987, Circulation research.
[44] P Bie,et al. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. , 1986, The American journal of physiology.
[45] R. Kenny,et al. HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPE , 1986, The Lancet.
[46] E. Potter. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: Neuromodulation by neuropeptide Y? , 1985, Neuroscience Letters.
[47] M. N. Levy,et al. Cardiac sympathetic-parasympathetic interactions. , 1984, Federation proceedings.
[48] B. Wallin,et al. Sympathetic outflow to muscles during vasovagal syncope. , 1982, Journal of the autonomic nervous system.
[49] D. Goldstein,et al. Circulatory control mechanisms in vasodepressor syncope. , 1982, American heart journal.
[50] W. Kapoor,et al. Syncope of unknown origin. The need for a more cost-effective approach to its diagnosis evaluation. , 1982, JAMA.
[51] J. Holaday,et al. Opiate antagonist improves neurologic recovery after spinal injury. , 1982, Science.
[52] M. Thames,et al. Interaction between carotid and cardiopulmonary baroreflexes in control of plasma ADH. , 1981, The American journal of physiology.
[53] E. Muscholl. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. , 1980, The American journal of physiology.
[54] D. Donald,et al. Reflexes from the heart and lungs: physiological curiosities or important regulatory mechanisms. , 1978, Cardiovascular research.
[55] G. Rousseau. Purinergic Nerves , 1977, The Lancet.
[56] B. Chipperfield,et al. MAGNESIUM IN HEART MUSCLE , 1976, The Lancet.
[57] E. Braunwald,et al. The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. , 1970, The Journal of clinical investigation.
[58] D. A. Blair,et al. Excitation of cholinergic vasodilator nerves to human skeletal muscles during emotional stress , 1959, The Journal of physiology.
[59] L. Mont,et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. , 1995, Journal of the American College of Cardiology.
[60] K. Lurie,et al. Characterization of subcutaneous microvascular blood flow during tilt table-induced neurally mediated syncope. , 1995, Journal of the American College of Cardiology.
[61] C. Morillo,et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. , 1993, Journal of the American College of Cardiology.
[62] R. Sutton,et al. Proposed classification for tilt induced vasovagal syncope , 1992 .
[63] B. Ditto,et al. Baroreflex sensitivity at rest and during stress in individuals with a history of vasovagal syncope. , 1991, Journal of psychosomatic research.
[64] J. Ludbrook,et al. Sympathoadrenal mechanisms in cardiovascular responses to naloxone after hemorrhage. , 1987, The American journal of physiology.
[65] M. Brody. Histaminergic and Cholinergic Vasodilator Systems , 1978 .